SunTrust

The craze for Sarepta Therapeutics Inc (NASDAQ: SRPT) shares continued into its second day, gaining about 15 percent on Tuesday. The stock nearly doubled from the $28.15 recorded on September 16. Two catalysts likely responsible for this rally include the FDA approval for the company's Duchenne...

SunTrust said the "logical decision" for the FDA would be to deny approval for Sarepta Therapeutics Inc (NASDAQ: SRPT)'s Eteplirsen drug for the treatment of Duchenne Muscular Dystrophy. DMD is a genetic disorder caused by an absence of dystrophin, a protein that helps keep muscle...

Close on the heels of Belden Inc. (NYSE: BDC) shares hitting a 52-week high of $75.91 on September 2, SunTrust analyst William Stein downgraded the stock to a Neutral rating. The comments come in the wake of the stock recording more than 50 percent gain in the year-to-date period ending September 6...

The world of social media is evolving on a seemingly weekly basis, and investors in the space must keep up with the latest trends to stay ahead of the game. SunTrust analyst Robert "Bob" Peck recently discussed three topics that have had a major impact on the social media space in the second half...

On Thursday, CNBC reported that activists might be looking at Twitter Inc (NYSE: TWTR) ahead of next Thursday’s board meeting. However, the media outlet was not alone in suggesting activist action. On Wednesday, former chairman and CEO Ev Williams said on Bloomberg that the company needed to...

SunTrust maintains its Neutral rating on the shares of Kate Spade & Co (NYSE: KATE), saying that the company's initiatives may not be enough to offset external headwinds. The company reported lower-than-expected second-quarter earnings and cut its full-year guidance reflecting the second-...

SunTrust kept its Neutral rating on Herbalife Ltd. (NYSE: HLF) shares unchanged despite a beat and raise quarter from the nutrition company. "[W]e remain Neutral on the name given (1) valuation at >14x 2016E EPS (10-16x historical) and (2) the potential for choppiness/hiccups as it implements new...

Bob Peck and his team at SunTrust don't believe Twitter Inc (NYSE: TWTR) is up for sale, responding to reports that Steve Ballmer and Saudi Arabian Prince Al-Waleed bin Talal were interested in acquiring the social media company for $22 to $26 per share. While the firm tends to avoid...

SunTrust maintains its Buy rating on Whole Foods Market, Inc. (NASDAQ: WFM), despite saying traffic is still a "bigger challenge" for the organic foods retailer. Whole Foods reported $0.37 per share in its third-quarter earnings, in line with the consensus/Street estimates. Same-store sales in the...

The strong second-quarter results of Facebook Inc (NASDAQ: FB) reinforced the bullish thesis of SunTrust's Robert "Bob" Peck, as the social media giant's quarterly numbers trumped the estimates of both Peck and the Street handsomely. Q2, In Review Facebook's second-quarter EPS/revenue of $0.97/$6....

SunTrust's Robert "Bob" Peck said Match Group Inc (NASDAQ: MTCH) is likely to benefit from strong paid member count growth in the second quarter. "Ahead of the 2Q earnings we believe 1) another ~220 million paid member counts (PMCs) added with a majority from Tinder," Peck wrote in a note. Peck...